| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 08/08/2002 | CA2436281A1 Chimeric molecules containing a module able to target specific cells and a module regulating the apoptogenic function of the permeability transition pore complex (ptpc) |
| 08/08/2002 | CA2436092A1 Modified antibodies and methods of use |
| 08/08/2002 | CA2435958A1 Pyrimidine compounds and methods for making and using the same |
| 08/08/2002 | CA2435709A1 Hair follicle neogenesis by injection of follicle progenitor cells |
| 08/08/2002 | CA2434872A1 Medicament compositions with negligible side-effects containing betamimetics |
| 08/08/2002 | CA2434495A1 Ophthalmic compositions for treating ocular hypertension |
| 08/08/2002 | CA2434485A1 Ophthalmic compositions for treating ocular hypertension |
| 08/08/2002 | CA2433553A1 Pharmaceutical compositions including sampatrilat dispersed in a lipoidic vehicle |
| 08/08/2002 | CA2426587A1 Stabilization of radiopharmaceutical compositions using hydrophilic thioethers and hydrophilic 6-hydroxy chromans |
| 08/08/2002 | CA2426582A1 Gene delivery formulations and methods for treatment of ischemic conditions |
| 08/07/2002 | EP1229124A1 Nucleic acid transporter containing polypeptide and recombinant virus vector |
| 08/07/2002 | EP1229112A1 Alpha-isomaltosylglucosaccharide synthase, process for producing the same and use thereof |
| 08/07/2002 | EP1229050A2 Water insoluble derivatives of polyanionic polysaccharides |
| 08/07/2002 | EP1229048A1 Thromboplastin reagent and method for manufacturing the same |
| 08/07/2002 | EP1229045A1 Universal carrier for targeting molecules to Gb3 receptor expressing cells |
| 08/07/2002 | EP1228763A1 Multiparticulate formulations of lithium salts for once-a-day administration |
| 08/07/2002 | EP1228762A2 Method for preparation of disodium pamidronate |
| 08/07/2002 | EP1228761A2 Liquid pharmaceutical composition for treating bone diseases |
| 08/07/2002 | EP1228757A1 Stable pharmaceutical solutions of nimesulide |
| 08/07/2002 | EP1228755A1 Use of biodegradable microspheres for the delivery of an anticancer agent for the treatment of gliblastoma |
| 08/07/2002 | EP1228705A2 Process to produce dry powder of a carotenoid or several carotenoids |
| 08/07/2002 | EP1228236A2 Compositions for transfecting nucleic acids and their use |
| 08/07/2002 | EP1228214A2 Erythropoietin forms with improved properties |
| 08/07/2002 | EP1228199A2 Method for directed packaging of molecular substances in protein shells |
| 08/07/2002 | EP1228147A1 Dye labeled imidazoquinoline compounds |
| 08/07/2002 | EP1228125A2 Process for making aqueous coated beadlets |
| 08/07/2002 | EP1228089A2 Salt form of a conjugate useful in the treatment of prostate cancer |
| 08/07/2002 | EP1228077A1 Ruthenium (ii) complexes with high antitumoral and antimetastatic activities |
| 08/07/2002 | EP1228072A1 Pdgf receptor kinase inhibitory compounds, their preparation, purification and pharmaceutical compositions including same |
| 08/07/2002 | EP1228032A1 Compositions containing hydroxyeicosatetraenoic acid derivatives and methods of use in treating dry eye disorders |
| 08/07/2002 | EP1228028A1 Hydroxyeicosatetraenoate salts, compositions and methods of use in treating dry eye disorders |
| 08/07/2002 | EP1227877A1 Polydisperse double emulsion, corresponding monodisperse double emulsion and method for preparing the monodisperse emulsion |
| 08/07/2002 | EP1227848A2 Method for linking molecular substances |
| 08/07/2002 | EP1227835A1 Protease inhibitors as modulators of periodontal wound healing |
| 08/07/2002 | EP1227824A1 Transplant/implant device and method for its production |
| 08/07/2002 | EP1227821A1 Therapeutic compositions and methods of use thereof |
| 08/07/2002 | EP1227820A2 Oligosaccharide aldonic acids and their topical use |
| 08/07/2002 | EP1227817A1 Ciclesonide-containing aqueous pharmaceutical composition |
| 08/07/2002 | EP1227802A1 Film preparation for biphasic release of pharmacologically active or other substances |
| 08/07/2002 | EP1227801A2 Multi-layer preparation in film form, consisting of hydrophilic polymers, for the rapid release of active ingredients |
| 08/07/2002 | EP1227800A1 Osmotic controlled release drug delivery device |
| 08/07/2002 | EP1227797A2 Solid dispersion pharmaceutical formulations |
| 08/07/2002 | EP1227795A2 Lipid complex of alkycyclines |
| 08/07/2002 | EP1227794A2 Method for encapsulating proteins or peptides in liposomes, liposomes produced using said method, and their use |
| 08/07/2002 | EP1227780A2 A stable aqueous dispersion of nutrients |
| 08/07/2002 | EP1156789A4 Therapy for human cancers using cisplatin and other drugs or genes encapsulated into liposomes |
| 08/07/2002 | EP1140353B1 Preparation of multiwall polymeric microcapsules from hydrophilic polymers |
| 08/07/2002 | EP1069892B1 Therapeutic system which can be moisture-activated |
| 08/07/2002 | EP1024795B1 Controlled release formulations |
| 08/07/2002 | EP1019016B1 Active synergetic complex and cosmetic and/or pharmaceutical product containing this complex |
| 08/07/2002 | EP1007094B1 Pharmaceutical compositions comprising a nucleotide analogue suitable for freeze drying |
| 08/07/2002 | EP0831856B1 Use of hydroxyethyl starch to prevent post surgical adhesion and as an intracavity carrier device |
| 08/07/2002 | EP0817615B1 Peroral composition for controlled release in the lower gastrointestinal tract |
| 08/07/2002 | EP0805690B1 Method for selective methionine starvation of malignant cells in mammals |
| 08/07/2002 | EP0729781B1 Liposome comprising a membrane wall composed of a trehalose fatty acid ester |
| 08/07/2002 | EP0727996B1 Fenbendazole formulations |
| 08/07/2002 | EP0701434B1 Preparations containing silicon dioxide to improve the taste thereof |
| 08/07/2002 | EP0689434B1 Pharmaceutical compositions comprising paracetamol and l-cysteine or a precursor thereof |
| 08/07/2002 | EP0680495B1 Structured copolymers used as carriers of metal ions |
| 08/07/2002 | CN1362968A Novel peptides |
| 08/07/2002 | CN1362883A Stable composition comprising epidermal growth factor as active ingredient |
| 08/07/2002 | CN1362879A Patches containing buprenorphine hydrochloride |
| 08/07/2002 | CN1362878A Pharmaceutical preparation containing the active substance heroin and its utilization in a method for treating opiate addiction |
| 08/07/2002 | CN1362873A Gelled aqueous cosmetic compositions |
| 08/07/2002 | CN1362060A Prepn of nano hydroxycamptothecine-dextran grain |
| 08/07/2002 | CN1088721C Interferon conjugates |
| 08/07/2002 | CN1088716C Partially acylated Beta-cyclodextrins, their preparation method and use |
| 08/07/2002 | CN1088710C Water soluble repamycin esters |
| 08/07/2002 | CN1088600C Use of bruffen-beta-cyclodextrin matches |
| 08/07/2002 | CN1088599C Therapeutic compositions comprising antigen or an in vivo generator comprising amino-acid serial compounds |
| 08/07/2002 | CN1088587C Topical anti-inflammatory compositions containing piroxican |
| 08/07/2002 | CN1088583C Stable freeze-dried formulation comprising protein and assay kit |
| 08/07/2002 | CN1088581C Aerosol formulations of peptides and proteins |
| 08/07/2002 | CN1088580C Aerosol drug formulations |
| 08/06/2002 | US6429297 Modified avidin and streptavidin and methods of use thereof |
| 08/06/2002 | US6429230 Treating chronic uremic patients undergoing periodical dialysis |
| 08/06/2002 | US6429228 Local anesthetic for external use |
| 08/06/2002 | US6429227 Hydroxyeicosatetraenoate salts, compositions and methods of use in treating dry eye disorders |
| 08/06/2002 | US6429223 Modified forms of pharmacologically active agents and uses therefor |
| 08/06/2002 | US6429218 Applying a serum, cream, or lotion containing extra niacin to treat skin disorders such as acne, blackheads, fine lines, and enlarged pores; concentration is sufficient to produce warmth, blush, flushing or redness of skin |
| 08/06/2002 | US6429202 Administering complex with phospholipids to prevent atherosclerosis and myocardial or cerebral infarctions; reduces formation of arterial plaques |
| 08/06/2002 | US6429187 Method of diagnosing and treating gliomas |
| 08/06/2002 | US6428837 Deesterified pectins, processes for producing such pectins, and stabilized acidic liquid systems comprising the same |
| 08/06/2002 | US6428821 Oral micro-emulsion composition of silybin |
| 08/06/2002 | US6428815 Multifluid atomization of a dispersed system of a biologically active agent and a solvent to produce droplets; freezing the droplets; lyophilizing the frozen droplets obtain microstructures capable of being further fragmented |
| 08/06/2002 | US6428814 Stabilizers prevent aggregation of nanoparticles and increase bioadhesion to substrates such as an insect, teeth, bone, nails, chitin, feathers, scales, mucous, skin, hair, and/or plant tissue |
| 08/06/2002 | US6428811 Temperature-sensitive polymer/nanoshell composites for photothermally modulated drug delivery |
| 08/06/2002 | US6428810 Core material comprising active ingredient and optionally an alkalinity agent, hydroxypropyl cellulose separating layer and enteric coating; consistant release rate; storage stability |
| 08/06/2002 | US6428805 Powdery nasal compositions |
| 08/06/2002 | US6428790 Using viricidal polypeptides on solid supports for prophylaxis of human t-cell leukemia/lymphoma virus; antibodies |
| 08/06/2002 | US6428788 Preferential drug delivery to tumors having interleukin receptors; side effect reduction |
| 08/06/2002 | US6428780 Modified amino acid |
| 08/06/2002 | CA2130832C Virus-targeted biocatalysts |
| 08/06/2002 | CA2122714C Materials comprising and methods of preparation and use for ribosome-inactivating proteins |
| 08/06/2002 | CA2057010C Anti-idiotypic antibody which induces an immune response against a glycosphingolipid and use thereof |
| 08/05/2002 | CA2370355A1 Multiparticulate formulations of lithium salts for oral administration suitable for once-a-day administration |
| 08/01/2002 | WO2002059291A2 Biological organism for preparing pharmaceutical compositions for treating mammals |
| 08/01/2002 | WO2002059261A2 Inhibition of restenosis using a dna-coated stent |
| 08/01/2002 | WO2002059179A2 Synthesis of high molecular weight non-peptidic polymer derivatives |
| 08/01/2002 | WO2002059147A2 Activatable cytolytic or drug delivery peptides and uses thereof |